Target intelligence / Profile preview

AT-hook containing transcription factor 1 (AHCTF1)

Target
AHCTF1
Molecular classification
Transcription factor, Nucleoporin, Nuclear envelope protein, DNA-binding protein
01

Overview

AT-hook containing transcription factor 1 (AHCTF1, frequently referred to as ELYS) is a multifunctional protein required for assembly of the nuclear pore complex (NPC) during post-mitotic nuclear envelope reformation[1][3]. It enables DNA binding via an AT-hook motif, which allows direct interaction with nucleosomes—this is essential for recruiting and organizing NPC components on chromatin. Beyond its structural roles at the nuclear envelope, AHCTF1 regulates gene expression and is implicated in the efficient nucleocytoplasmic export of transcripts, notably promoting oncogenic MYC expression in some cancer types by serving as a nuclear tether for active gene alleles[1]. AHCTF1 also contributes to genome stability in certain stem and progenitor cell types, and its loss can invoke DNA damage responses even without apparent defects in NPC assembly. Pathologically, AHCTF1 is linked to tumor cell growth via super-enhancer-mediated MYC activation in cancer and congenital contracture syndromes. It is predominantly classified as a transcription factor with nucleoporin and chromatin-binding functions[1][3][7].

Other names
ELYSMST108MSTP108TMBS62Embryonic large molecule derived from yolk sacProtein MEL-28ELYS transcription factor-like protein TMBS62Putative AT-hook-containing transcription factor 1
02

Biological functions

Nuclear pore complex assemblyChromatin bindingRegulation of cytokinesisDNA bindingRegulation of gene expressionGenome stability maintenanceNucleocytoplasmic transport
03

Disease associations

Cancer (MYC oncogene regulation, colorectal cancer)[1][3]Autoimmune lymphoproliferative syndrome[3]Lethal congenital contracture syndrome 1[3]Other (roles in tissue development, especially intestinal epithelium)[1]
04

Safety considerations

Essential for genome stability—knockdown triggers DNA damage response in some tissues[1]Involved in cell cycle and nuclear envelope integrity, suggesting toxicity risk if therapeutically targeted[1][3]

Beyond the preview

Go deeper on AT-hook containing transcription factor 1 (AHCTF1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AT-hook containing transcription factor 1 (AHCTF1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call